InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.027

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Notification regarding unquoted securities - FRE 29 Aug 2025 3:47PM $0.075 $0.027 fallen by 64%
$8 Application for quotation of securities - FRE 29 Aug 2025 3:45PM $0.075 $0.027 fallen by 64%
$8 Application for quotation of securities - FRE 29 Aug 2025 3:44PM $0.075 $0.027 fallen by 64%
$8 Appendix 4G 29 Aug 2025 3:34PM $0.075 $0.027 fallen by 64%
$8 Corporate Governance Statement 29 Aug 2025 3:34PM $0.075 $0.027 fallen by 64%
$8 Appendix 4E and Annual Report 30 June 2025 29 Aug 2025 3:33PM $0.075 $0.027 fallen by 64%
$8 Appendix 4E and Annual Report 30 June 2025 29 Aug 2025 3:33PM $0.075 $0.027 fallen by 64%
$8 Proposed issue of securities - FRE 26 Aug 2025 8:10AM $0.074 $0.027 fallen by 63.51%
$8 Firebrick Secures $1.4 million via Placement 26 Aug 2025 8:10AM $0.074 $0.027 fallen by 63.51%
$8 License Agreement for Singapore, Malaysia, Brunei, Mauritius 26 Aug 2025 8:09AM $0.074 $0.027 fallen by 63.51%
$8 Nasodine COVID-19 Patent Granted in Australia 25 Aug 2025 8:13AM $0.075 $0.027 fallen by 64%
$8 Nasodine COVID-19 Patent Accepted in Europe 13 Aug 2025 8:18AM $0.080 $0.027 fallen by 66.25%
$8 Notification regarding unquoted securities - FRE 1 Aug 2025 11:27AM $0.077 $0.027 fallen by 64.94%
$8 Initial Director's Interest Notice - Rick Legleiter 1 Aug 2025 11:21AM $0.077 $0.027 fallen by 64.94%
$8 Notification of cessation of securities - FRE 30 Jul 2025 12:33PM $0.077 $0.027 fallen by 64.94%
$8 Proposed issue of securities - FRE 28 Jul 2025 8:25AM $0.077 $0.027 fallen by 64.94%
$8 Firebrick Appoints Rick Legleiter as Director 28 Jul 2025 8:25AM $0.077 $0.027 fallen by 64.94%
$8 June 2025 Quarterly Activity Report & Appendix 4C 23 Jul 2025 8:14AM $0.064 $0.027 fallen by 57.81%
$8 Notification regarding unquoted securities - FRE 4 Jul 2025 5:50PM $0.063 $0.027 fallen by 57.14%
$8 Cleansing Notice 4 Jul 2025 5:37PM $0.063 $0.027 fallen by 57.14%
$8 Application for quotation of securities - FRE 4 Jul 2025 5:33PM $0.063 $0.027 fallen by 57.14%
$8 Proposed issue of securities - FRE 26 Jun 2025 9:08AM $0.070 $0.027 fallen by 61.43%
$8 Firebrick Closes Placement at $0.2 milliion 26 Jun 2025 9:08AM $0.070 $0.027 fallen by 61.43%
$8 Trading Halt 24 Jun 2025 9:03AM $0.070 $0.027 fallen by 61.43%
$8 Firebrick Pharma Investor Presentation 23 June 2025 23 Jun 2025 3:06PM $0.072 $0.027 fallen by 62.50%

101 - 125 of 523 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.